研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年的期刊文章 · 第 21 页
共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-05-30 到 2026-05-21。
按期刊、按主题看 →
SiM Bayesian Methods · 发表于 2026-05-30,收录于 2026-06-05
Marco Ratta, Gaëlle Saint‐Hilary, Mauro Gasparini, Pavel Mozgunov
摘要
Robust Mixture Prior (RMP) is a popular Bayesian dynamic borrowing method, which combines an informative historical distribution with a less informative component (referred to as the robustification component ) in a mixture prior to enhance the efficiency of hybrid‐control randomized trials. Current practice typically focuses solely on the selection of the prior weight that governs the relative influence of these two components, often fixing the variance of the robustification component to a unit‐information variance. In this study we demonstrate that the performance of RMPs critically depends on the joint selection of both weight and variance of the robustification component. In particular, we show that a wide range of weight‐variance pairs can yield practically identical posterior inferences (in particular regions of the parameter space) and that large variance robust components may be employed without incurring the so called Lindley's paradox . We further show that the use of large variance robustification components leads to improved asymptotic type I error rate control and enhanced robustness of the RMP to the specification of the location parameter of the robustification component. Finally, we leverage these theoretical results to propose a novel and practical hyper‐parameter elicitation routine.
Biometrics Causal Inference Bayesian Methods Latent Variables & Mixtures · 发表于 2026-05-30,收录于 2026-06-05
Dafne Zorzetto, Jenna Landy, Corwin Zigler, Giovanni Parmigiani, Roberta De Vito
摘要
(verbatim, from OUP article-abstract page): "The impact of wildfire smoke on air quality is a growing concern, contributing to air pollution through a complex mixture of chemical species with important implications for public health. Although previous studies have focused mainly on its association with total particulate matter (pm2.5), the causal relationship between wildfire smoke and the chemical composition of pm2.5 remains largely unexplored. To fill this gap, we propose a Bayesian causal regression factor model that estimates the multivariate causal effects of wildfire smoke on the concentration of 27 chemical species in pm2.5 across the United States. Our approach introduces two key innovations: (i) a causal inference framework for multivariate potential outcomes, and (ii) a novel Bayesian factor model that employs a probit stick-breaking process as prior for treatment-specific factor scores. By focusing on factor scores, our method addresses the missing data challenge common to causal inference and enables a flexible, data-driven characterization of the latent factor structure, which is crucial to capturing the complex correlation between multivariate outcomes. Through Monte Carlo simulations, we show the accuracy of the model in estimating the causal effects in multivariate outcomes and characterizing the treatment-specific latent structure. Finally, we apply our method to US air quality data, estimating the causal effect of wildfire smoke on 27 chemical species in pm2.5, providing a deeper understanding of their interdependencies." *(Note: subscript "pm₂.₅" in the source has been rendered as "pm2.5" here.)*
Biometrics Genetics & Omics · 发表于 2026-05-30,收录于 2026-06-05
Troy P Wixson, Benjamin A Shaby, Daisy L Philtron, Leandro A Lima, Stacia K Wyman, Julia A Kaye, Steven Finkbeiner
摘要
We seek to identify genes involved in Parkinson’s disease (PD) by combining information across different experiment types. Each experiment, taken individually, may contain too little information to distinguish some important genes from incidental ones. However, when experiments are combined using the proposed statistical framework, additional power emerges. The fundamental building block of the family of statistical models that we propose is a hierarchical three-groups mixture of distributions. Each gene is modeled probabilistically as belonging to either a null group that is unassociated with PD, a deleterious group, or a beneficial group. This three-groups formalism has two key features. By apportioning prior probability of group assignments with a Dirichlet distribution, the resultant posterior group probabilities automatically account for the multiplicity inherent in analyzing many genes simultaneously. By building models for experimental outcomes conditionally on the group labels, any number of data modalities may be combined in a single coherent probability model, allowing information sharing across experiment types. These two features result in parsimonious inference with few false positives, while simultaneously enhancing power to detect signals. Simulations show that our three-groups approach performs at least as well as commonly-used tools for GWAS and RNA-seq, and in some cases it performs better. We apply our proposed approach to publicly available genome-wide association studies and RNA-seq datasets, discovering novel genes that are potential therapeutic targets.
Biometrics Other · 发表于 2026-05-29
Cathy Shyr
SiM Causal Inference Survival Analysis Longitudinal Data · 发表于 2026-05-28,收录于 2026-06-05
Lantian Xu, Susan Murray
摘要
When evaluating treatment effects in progressive disease clinical trials, analyses of time to recurrent or terminal events largely ignore (or separately analyze) functional measures of disease progression over time. For instance, in pulmonary research settings, treatment may impact recurrent times‐to‐hospitalization, mortality and pulmonary function during follow‐up. Ignoring longitudinal pulmonary function in two‐sample tests for recurrent and terminal events is not only a potential waste of statistical information that could help power the study, but also misses the daily impact of treatment on the ability to breathe that comprises the majority of the follow‐up period. In this manuscript, we develop a two‐sample testing procedure that analyzes recurrent and terminal events, also taking into account pulmonary health over time as a health history state with a corresponding utility function. Our proposed test compares the longitudinal profiles of ‐restricted, utility‐adjusted event‐free times across multiple follow‐up windows. Asymptotic limiting behavior of our test statistic is given along with finite sample formulas and graphical summaries convenient for use in data analysis. Simulations demonstrate good performance of the testing procedure. Simulated power results give insight into strengths and limitations of incorporating health history utilities into the analysis with gains demonstrated when treatment improves both event rates and health history. We further apply this method to the Azithromycin for Prevention of COPD Exacerbation Trial to show its practical use.
Biometrics Survival Analysis Clinical Trials · 发表于 2026-05-27,收录于 2026-05-29
Michael J Martens, Qinghua Lian, Brent R Logan
摘要
Safety evaluation is an essential component of clinical trials. To protect study participants, these studies often implement safety stopping rules that will halt the trial if an excessive number of toxicity events occur. Existing safety monitoring methods usually treat these events as binary outcomes. A strategy that instead handles these as time-to-event (TITE) endpoints can offer higher power and a reduced time to signal of excess risk, but must manage additional complexities including censoring and competing risks. We propose the TITE-safety approach for safety monitoring, which incorporates TITE information while handling repeated analyses, censored observations, and competing risks appropriately. This strategy is applied to develop stopping rules using score tests, Bayesian beta-extended binomial models, and sequential probability ratio tests. Operating characteristics of these methods are studied via simulation for common phase 2 and 3 trial scenarios. Across simulation settings, the proposed techniques offer reductions in expected toxicities of 20% or more compared to binary data methods and maintain the type I error rate near the nominal level for various event time distributions. These methods are demonstrated through a redesign of the safety monitoring scheme for Blood and Marrow Transplant Clinical Trials Network 0601, a single arm, phase 2 trial that evaluated bone marrow transplant as treatment for sickle cell disease. Our R package “stoppingrule” offers functions to construct and evaluate these stopping rules, providing valuable tools for trial design to investigators.
Biometrics Survival Analysis Nonparametric & Semiparametric Diagnostics & Prediction · 发表于 2026-05-27,收录于 2026-05-29
Tonghui Yu, Liming Xiang
摘要
Cardiovascular diseases are major causes of mortality globally. They often co-occur and are interrelated, leading to partial-order relationships among their onset times. However, these onset times are subject to informative censoring due to the occurrence of death, posing significant challenges for survival prediction. In this paper, we propose a novel copula-based framework that learns dependence among multiple correlated marginal components through a pseudo-likelihood for estimation. We adopt nonparametric marginals, alleviating the reliance on marginal distribution assumptions typically required in conventional copula models, and estimate the association between the onsets of intermediate cardiovascular diseases and death by solving a concordance estimating equation. Under this framework, a renewable risk assessment method is developed for dynamic survival prediction, leveraging information on disease onset times and the maximum follow-up duration. Our proposed method yields estimators with well-established properties, and its flexibility and predictive effectiveness are demonstrated through extensive simulation studies. We apply the method to data from a heart disease study, demonstrating the benefits of incorporating the associations among various cardiovascular diseases and their synergistic effects on mortality for dynamic prediction of overall survival.
Biometrics Meta-Analysis & Data Integration Latent Variables & Mixtures · 发表于 2026-05-27,收录于 2026-05-29
Xuetong Li, Shuyuan Wu, Bin Du, Hansheng Wang
摘要
We systematically study several network-based Expectation–Maximization (EM) algorithms for the Gaussian mixture model within decentralized federated learning (DFL). Our theoretical investigation reveals that directly extending the classic EM algorithm to DFL leads to a seriously biased estimator if the data are heterogeneously distributed across different sites. To address this issue, we introduce a momentum network EM (MNEM) algorithm, which integrates information from both current and historical estimators from previous DFL iterations. We further develop a semi-supervised MNEM (semi-MNEM) algorithm, which utilizes valuable information provided by partially labeled data. Rigorous theoretical analysis demonstrates that the MNEM estimator can achieve the same asymptotic efficiency as the whole sample estimator under appropriate regularity conditions, even if the data are heterogeneously distributed. Moreover, the semi-MNEM estimator significantly improves the convergence speed of the MNEM algorithm, even if different mixture components are poorly separated. Extensive simulations are conducted, and a widely used chest X-ray dataset is analyzed to demonstrate the finite-sample performance of the proposed methods.
SiM Clinical Trials Bayesian Methods Diagnostics & Prediction · 发表于 2026-05-27,收录于 2026-05-29
Weishi Chen, Pavel Mozgunov
摘要
The increased interest in the combination of drug agents and/or schedules requires more flexible model‐based designs for Phase I clinical trials. The models often involve more design parameters, which have to be specified before starting the trial. Those are often chosen from statistical considerations, that is, need to be optimized in a simulation study. Consequently, an efficient and systematic way for parameter calibration will both improve the model performance and save computational time. The conventional “grid search” calibration approach requires large simulations, which are computationally costly. A novel “cyclic calibration” has been proposed to reduce the computation from multiplicative to additive. Furthermore, calibration processes should consider a wide range of scenarios of true toxicity probabilities to avoid bias. A method to reduce scenarios based on scenario complexity is suggested. This can reduce the computation by more than 500‐fold, while maintaining operational characteristics similar to the grid search.
SiM Clinical Trials · 发表于 2026-05-26,收录于 2026-05-29
Maria Vittoria Chiaruttini, Lukas Pin, Sofía S. Villar
摘要
The majority of response‐adaptive randomization (RAR) designs in the literature rely on efficacy data to guide dynamic patient allocation. However, their applicability becomes limited in settings where efficacy outcomes, such as survival, are observed with a random delay. To address this limitation, we introduce SAFER, a novel RAR design that leverages early‐emerging safety data to inform treatment allocation decisions, particularly in oncology trials. The design is broadly applicable to contexts where prioritizing the arm with superior safety is desirable. This is especially relevant in noninferiority trials, to demonstrate that an experimental treatment is not inferior to the standard of care, while potentially offering improved tolerability. In such trials, an unavoidable trade‐off arises: maintaining statistical efficiency for the efficacy hypothesis while integrating safety‐driven adaptations through RAR. The SAFER design addresses this trade‐off by dynamically adjusting the allocation proportion based on the observed association between safety and efficacy endpoints. We illustrate the performance of SAFER through a simulation study inspired by the CAPP‐IT Phase III oncology trial. Results show that SAFER preserves statistical power, reduces the adverse event rate, and offers flexible adaptation speed depending on the temporal alignment of the endpoints.
JASA Econometrics & Economics · 发表于 2026-05-26,收录于 2026-05-29
H. Peter Boswijk, Roger J. A. Laeven, Andrei Lalu, Evgenii Vladimirov
摘要
We analyze the contagious propagation of jumps among international stock market indices, using a rich panel of high-frequency stock and options data ( 692,892 option contracts) over the period 2006–2015. We propose a bivariate option pricing model designed to allow for time and space amplification of jumps in option markets. We develop a semi-parametric estimation procedure, which employs a continuum of moment conditions in GMM with implied states and non-parametric high-frequency spot volatility estimation. A partial-information approach is introduced to reduce the computational complexity arising in the multivariate setting. We find statistical evidence of jump contagion both within and between stock market indices. Our results reveal that jump contagion from the US to the UK is more pronounced than vice versa, whereas the jump contagion effects between the US and Germany stand on equal footing. We illustrate the statistical and economic importance of capturing jump contagion for risk management, option pricing, and scenario analysis. We show that accounting for jump contagion, employing scenarios based on the Global Financial Crisis, leads to an increase of capital requirements in the UK from 6.3% to 8.4% for each unit invested. *(abstract via OpenAlex)*
SiM Other · 发表于 2026-05-26,收录于 2026-05-29
Antonio Olivas‐Martinez, Fei Gao, Holly Janes
摘要
Active‐controlled trials with non‐inferiority objectives are often used when effective interventions are available, but new options may offer advantages or meet public health needs. In these trials, participants are randomized to an experimental intervention or an active control. The traditional non‐inferiority criterion requires that the new intervention preserve a substantial proportion of the active control effect. A key challenge is the absence of a placebo arm, which necessitates reliance on historical data to estimate the active control effect and assumptions about how well this effect applies to the target population. Another challenge arises when the active control is highly effective, as the new intervention may still be valuable even if it does not meet the traditional criterion. This has motivated alternative criteria based on sufficient efficacy relative to a hypothetical placebo. In this work, we propose a general framework for designing and evaluating non‐inferiority trials that integrates all existing analytical methods and accommodates both traditional and alternative success criteria. The framework enables the systematic comparison of methods in terms of type I error, power, and robustness to misspecification of the active control effect. We illustrate its applicability in the design of a future HIV prevention trial with a highly effective active control. In this application, our framework identifies methods that provide greater efficiency and robustness than commonly used approaches and demonstrates practical advantages of the alternative non‐inferiority criterion. Overall, this framework offers a comprehensive toolkit for rigorous non‐inferiority trial design, supporting method selection and the evaluation of new interventions.
SiM High-Dimensional · 发表于 2026-05-25,收录于 2026-05-29
Xianwei Li, Liqun Diao, Richard J. Cook
摘要
The classical illness‐death process offers a useful framework for studying the progression of chronic disease while jointly modeling death. In many settings the time of disease progression is not observed directly, but progression status is recorded at intermittent assessment times. This creates a dual observation scheme where progression times are interval‐censored and death is subject to right censoring. We present a penalized observed data likelihood for variable selection in multiplicative intensity‐based models for the joint process, involving different penalty functions for different sets of regression coefficients. Optimization is carried out based on an innovative expectation‐maximization algorithm that can be implemented using existing software. Simulation studies demonstrate the finite sample performance of the method, and an application to a dementia study from the National Alzheimer's Coordinating Center (NACC) illustrates the insights that can be gained.
SiM Clinical Trials Optimization & Learning Theory · 发表于 2026-05-25,收录于 2026-05-29
Henry Bern, James Carpenter, Mahesh Parmar, Ian R. White, Matteo Quartagno
摘要
The Response Over Continuous Intervention (ROCI) design offers a number of potential benefits over conventional non‐inferiority trials in studies focused on the late‐phase optimization of a continuous aspect of treatment intervention. One possible application of this design is in de‐escalation trials, which aim to reduce the dose, duration, or frequency of an established treatment. In the absence of an alternative method, sample size requirements for the ROCI design are currently estimated through simulation, which is often time‐consuming and computationally intensive. We propose a normal approximation approach to sample size calculation and evaluate alternative methods for deriving nuisance parameter estimates (e.g., treatment effect variance), considering both the reliability of results and the computational resources required to generate them. Our analysis demonstrates that adopting sample size methodology based on normal approximation is well‐founded for the ROCI design and significantly reduces computational demands, though reliable estimation of distribution parameters typically requires methods that account for model selection uncertainty. The sample size estimation framework outlined in this paper follows previous recommendations for the ROCI design and employs fractional polynomial regression to model the intervention‐response curve; however, it generalizes beyond this and has potential utility for designs implementing alternative flexible modeling approaches.
SiM Survival Analysis Machine Learning Networks & Graphs · 发表于 2026-05-25,收录于 2026-05-29
Changhui Yuan, Shishun Zhao, Shuwei Li, Xinyuan Song, Zhao Chen
摘要
Deep neural networks (DNNs) have become powerful tools for modeling complex data structures through sequentially integrating simple functions in each hidden layer. In survival analysis, recent advances of DNNs primarily focus on enhancing model capabilities, especially in exploring nonlinear covariate effects under right censoring. However, deep learning methods for interval‐censored data, where the unobservable failure time is only known to lie in an interval, remain underexplored and limited to specific data types or models. This work proposes a general regression framework for interval‐censored data with a broad class of partially linear transformation models, where key covariate effects are modeled parametrically while nonlinear effects of nuisance covariates are approximated via DNNs, balancing interpretability and flexibility. We employ sieve maximum likelihood estimation by leveraging monotone splines to approximate the cumulative baseline hazard function. To ensure reliable and tractable estimation, we develop an EM algorithm incorporating stochastic gradient descent. We establish the asymptotic properties of parameter estimators and show that the DNN estimator achieves minimax‐optimal convergence. Extensive simulations demonstrate superior estimation and prediction accuracy over state‐of‐the‐art methods. Applying our method to the Alzheimer's Disease Neuroimaging Initiative dataset yields novel insights and improved predictive performance compared to traditional approaches.
Biometrics Causal Inference Bayesian Methods · 发表于 2026-05-25,收录于 2026-05-29
Chen Liu, Xu Qin, Victor B Talisa, Jiebiao Wang
摘要
Causal mediation analysis provides insights into the mechanisms through which treatments affect outcomes. While mediation effects often vary across individuals, most existing methods focus solely on population-average effects, overlooking individual-level heterogeneity. To address this limitation, we propose a Bayesian regression tree ensemble method that flexibly models nonlinear relationships and captures treatment-by-mediator interactions in the mediation process. Using hierarchical posterior sampling, our approach provides credible intervals with nominal coverage rates for inferring heterogeneous mediation effects. Additionally, we leverage regression tree summaries to identify subgroups with distinct mediation effects and employ SHapley Additive exPlanation values to highlight key moderators and their influence on the mediation process. Comprehensive simulations demonstrate the method’s accuracy in estimating and inferring heterogeneous mediation effects. Finally, we apply our method to investigate the heterogeneous mediation role of Alzheimer’s disease pathology burden in the effect of apolipoprotein E genotype on late-life cognition.
SiM Spatial & Time Series Testing & Uncertainty · 发表于 2026-05-25,收录于 2026-05-29
Junho Lee
摘要
Spatial cluster detection is widely used in fields such as epidemiology and environmental science to identify spatial units that exhibit patterns differing from background variation. While traditional methods like spatial scan statistics are effective in detecting clusters, they often lack tools to quantify and visualize the uncertainty surrounding detected clusters. In this work, we propose a novel framework for constructing confidence sets for spatial clusters, applicable to both Poisson and Normal models. Building on likelihood‐based methods, we leverage the p value of the likelihood ratio test statistic to construct confidence sets with empirical coverage close to nominal levels. To address computational complexity, we implement a binary search algorithm to efficiently determine significance thresholds. We also introduce two visualization tools: a confidence heatmap showing the chance of inclusion of each spatial unit in the true cluster, and confidence envelopes delineating the bounds of uncertainty. Simulation studies and an application to real cancer mortality data demonstrate the method's interpretability, robustness to non‐circular or multiple clusters, and practical utility. Our approach offers a principled alternative to traditional significance‐based methods and opens avenues for extensions to multiple cluster detection, spatio‐temporal analysis, and spatially varying regression models.
SiM Bayesian Methods Genetics & Omics High-Dimensional · 发表于 2026-05-25,收录于 2026-05-29
Kai Jiang, Satabdi Saha, Christine B. Peterson
摘要
Numerous studies have shown that microbial metabolites, which represent the products of bacteria in the human gut, play a key role in shaping cancer risk and response to treatment. However, metabolite data typically contain a large proportion of missing values, which may result from either low abundance or technical challenges in data processing. Moreover, given the compositionality of microbiome data, where the observed abundances can only be interpreted on a relative scale, standard variable selection methods are not applicable. In this project, we propose a novel Bayesian regression method to address these challenges in the integration of metabolite and microbiome data. Key features of our proposed model include modeling the two different mechanisms of missingness for the metabolite data and adopting a Bayesian prior designed to address the compositional characteristics of microbiome data. We demonstrate on simulated data that our proposed model can accurately impute the unobserved true metabolite values and correctly select the relevant microbiome predictors. We further illustrate our method using real data from a study focused on understanding the interplay between the microbiome and metabolome in colorectal cancer.
Biometrics Bayesian Methods Clinical Trials Testing & Uncertainty · 发表于 2026-05-25,收录于 2026-05-29
Amartya Kumar Maulik, Tianjian Zhou
摘要
Basket trials evaluate a single treatment across multiple patient subpopulations, posing important multiple testing problems. Motivated by this setting, we propose a novel Bayesian decision-theoretic approach based on a family of loss functions. These functions adaptively penalize false positives and false negatives based on the numbers of true null and alternative hypotheses, making a basket more likely to be identified as promising when others show promise. Estimation of treatment effects remains independent across baskets, avoiding the computational burden of existing hierarchical modeling approaches and allowing straightforward generalization to trials with different endpoints. The degree of borrowing and the conservativeness of decisions are controlled by tuning parameters, which can be calibrated to achieve desired control of frequentist error rates. The optimal Bayes decision rule is derived by minimizing the posterior expected loss and is computationally efficient. Simulation studies demonstrate that the proposed approach exhibits desirable operating characteristics, performing competitively with widely used alternatives. We illustrate its practical utility through an application to a basket trial of vemurafenib.
SMMR Survival Analysis Nonparametric & Semiparametric · 发表于 2026-05-23
Chyong-Mei Chen, Yingwei Peng
摘要
Quantile regressions offer several attractive features, including the ability to allow covariate effects to vary at different quantile levels and to effectively handle heteroscedasticity in data, which makes it a viable alternative for analyzing data with continuous outcomes in recent years. It has been used in modeling survival data with and without a cured fraction. In this work, we propose novel estimating equation approaches to estimate a mixture cure model where the latency survival time is modeled using a quantile regression. Our proposed estimation methods provide double robustness, meaning that a misspecification in one part of the mixture cure model will not affect the estimation in the other part. The methods relax the restrictive global log-linear assumption that is typically found in existing quantile regressions, and they allow for both quantile-varying and quantile-invariant effects in the regression when the log-linear assumption holds within a certain range of quantile levels. We established the asymptotic properties of the proposed estimators, and our simulation studies demonstrated their double robustness and efficiency gains. An application of the proposed model and methods to data from a lung cancer study revealed that uncured patients with adenocarcinoma have significantly longer quantiles in the survival time than uncured patients with squamous cell carcinoma, which had not been reported in previous analyses of the data due to the limitations of the existing methods.
SMMR High-Dimensional · 发表于 2026-05-23,收录于 2026-07-24
Not available
摘要
Over the past few decades, various advanced methods have been developed to facilitate information integration. These methods leverage summary statistics (e.g. point estimates) from multiple sites or studies, which can be readily extracted from existing publications or efficiently shared via correspondence, without requiring the sharing of raw individual-level data. Despite these advancements, existing methods may not be directly applicable to the model that allows certain covariate effects to vary with the values of another covariate. This model is widely used in biomedical research, particularly in scenarios where assuming linear effects across all covariates is inappropriate. This article addresses this gap by introducing a new information integration framework. This new framework (a) enables computationally efficient integration of information from a different external model type (e.g. generalized linear models), (b) does not assume homogeneous data distributions across sites or studies, and (c) supports variable selection. Extensive simulations validate the proposed method, demonstrating substantial variance reduction with minimal estimation bias in various cases. Finally, we apply this method to two distinct datasets to identify (a) risk factors influencing blood pressure using data from the UK Biobank and ARIC studies, and (b) risk factors associated with prolonged hospital length of stay among older fracture patients with ADRD using Medicare claims.
SiM Longitudinal Data 讨论 / 评论 · 发表于 2026-05-22
Gian Luca Di Tanna, Niklaus Meier, Matthias Schwenkglenks
摘要
Bang and Zhao address an important methodological gap by proposing meta‐analytic methods for cost‐effectiveness analysis (CEA) based on separate pooling of incremental costs (ΔC) and incremental effectiveness (ΔE), with summaries displayed on the cost‐effectiveness plane. We share the aim of expanding the toolkit for CEA synthesis; however, we believe that several issues need clarification before the proposal can serve as a general blueprint. First, the two motivating examples appear not to satisfy the key combinability criteria described by Shields and Elvidge. Second, the proposal does not incorporate the data harmonization steps recommended for the meta‐analysis of economic evaluations by Bagepally et al. Third, separate univariate pooling does not retain the within‐study association between ΔC and ΔE, which complicates the joint interpretation of the pooled ICER and its uncertainty. As a possible way forward, we propose a two‐stage framework in which a structured combinability assessment and data harmonization precede any quantitative synthesis, and discuss why joint modeling of (ΔC, ΔE) is preferable to separate univariate pooling. In our view, such a framework provides a more defensible route to pooled ICERs, joint uncertainty summaries, and decision‐relevant quantities such as cost‐effectiveness acceptability curves (CEACs).
SiM Causal Inference Missing Data & Measurement Error · 发表于 2026-05-22,收录于 2026-06-12
Hyunman Sim, Won Kyung Lee, Christoph Lange, Woojoo Lee
摘要
Estimating causal effects from observational studies with missing data typically requires the no unmeasured confounder (NUC) assumption and the missing at random (MAR) assumption. However, correctly specifying all relevant models is often challenging in practice, and model misspecification can lead to biased estimates. In this study, we develop a triply robust estimator for causal effects when the outcome or treatment variable is partially observed. The proposed estimator incorporates outcome, treatment, and missing‐data models, and remains consistent as long as at least two of the three models are correctly specified. Although this approach provides robustness against model misspecification, its validity still depends on the NUC and MAR assumptions, which are untestable from the observed data alone and may be frequently violated in the presence of unmeasured confounding. To address this limitation, we introduce a novel sensitivity analysis framework to evaluate the potential impact of unmeasured confounding on causal effect estimates and demonstrate its practical usefulness through an application to real data.
SiM Other · 发表于 2026-05-22
Heejung Bang, Hongwei Zhao
Biometrics Causal Inference High-Dimensional Bayesian Methods · 发表于 2026-05-21,收录于 2026-05-22
Jiefeng Bi, Matteo Borrotti, Bernardo Nipoti
摘要
A dynamic treatment regime is a sequence of medical decisions that adapts to the evolving clinical status of a patient over time. To facilitate personalized care, it is crucial to assess the probability of each available treatment option being optimal for a specific patient, while also identifying the key prognostic factors that determine the optimal sequence of treatments. This task has become increasingly challenging due to the growing number of individual prognostic factors typically available. In response to these challenges, we propose a Bayesian model for optimizing dynamic treatment regimes that addresses the uncertainty in identifying optimal decision sequences and incorporates dimensionality reduction to manage high-dimensional individual covariates. The first task is achieved through a suitable augmentation of the model to handle counterfactual variables. For the second, we introduce a novel class of spike-and-slab priors for the multi-stage selection of significant factors, to favor the sharing of information across stages. The effectiveness of the proposed approach is demonstrated through an extensive simulation study and illustrated using clinical trial data on severe acute arterial hypertension.
Biometrics Diagnostics & Prediction · 发表于 2026-05-21,收录于 2026-05-22
Kecheng Li, Richard J Cook
摘要
Multistate models offer an appealing framework for studying the onset and progression of chronic diseases in large cohort studies. Such studies often involve the collection and storage of biospecimens at an initial assessment, and intermittent observation of the disease process at future assessment times. We consider the design of two-phase biomarker studies in such settings where budgetary constraints prohibit assaying all biospecimens. A subsample of individuals is instead chosen to have their biospecimens assayed to facilitate examination of the association between a biomarker of interest and the disease process. Analyses based on likelihood, conditional likelihood, and estimating functions are considered, with the efficiency gains from various subsampling strategies investigated. Pseudo-score residual-dependent sampling strategies are shown to yield highly efficient maximum likelihood estimates of biomarker effects on disease progression. This sampling strategy along with competing methods are empirically studied and applied to a motivating study of the relationship between the HLA-B27 marker and joint damage in patients with psoriatic arthritis.
JASA Other · 发表于 2026-05-21,收录于 2026-05-29
Natalia Nolde, Chen Zhou, Menglin Zhou
摘要
In this article we address the problem of high quantile estimation conditional on a related variable being extreme. The problem set-up is of interest in a number applications to evaluate tail risk of a focal variable in the tail of a conditioning variable. A primary example we consider is the assessment of systemic risk in financial markets using a risk measure known as the conditional value-at-risk (CoVaR). The proposed estimator is based on a novel approach to handle the bivariate tail dependence structure through an adjustment factor that can be used in conjunction with univariate high quantile estimation techniques. We establish the asymptotic behavior of the estimator under relatively weak assumptions, and illustrate its performance via simulation studies and a real data example. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
JASA Spatial & Time Series · 发表于 2026-05-21,收录于 2026-05-29
Xinbing Kong, Bin Wu, Wuyi Ye
摘要
In this article, we propose a price staleness factor model that accounts for pervasive market friction across assets and incorporates relevant covariates. Using large-panel high-frequency data, we derive the maximum likelihood estimators of the regression coefficients, the nonstationary factors, and their loading parameters. These estimators recover the time-varying price staleness probabilities. We develop asymptotic theory in which both the dimension d and the sampling frequency n tend to infinity. Using a local principal component analysis (LPCA) approach, we find that the efficient price co-volatilities (systematic and idiosyncratic) are biased downward due to the presence of staleness. We provide bias-corrected estimators for both the spot and integrated systematic and idiosyncratic co-volatilities, and prove that these estimators are robust to data staleness. Interestingly, besides their dependence on the dimensionality d, the integrated plug-in estimates converge at a rate of n−1/2, whereas the LPCA estimates converge at a slower rate of n−1/4. This validates the aggregation efficiency achieved through nonlinear, nonstationary factor analysis via maximum likelihood estimation. Numerical experiments justify our theoretical findings. Empirically, we demonstrate that the staleness factor provides unique explanatory power for cross-sectional risk premia, and that the staleness correction reduces out-of-sample portfolio risk. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Survival Analysis Causal Inference · 发表于 2026-05-21,收录于 2026-06-05
Yuhao Deng, Rui Wang, Tao Zhang, Xiang Zhan
摘要
In clinical studies, the risk of the primary (terminal) event may be modified by intermediate events, resulting in semicompeting risks. To study the treatment effect on the terminal event mediated by the intermediate event, researchers wish to decompose the total effect into direct and indirect effects. In this article, we extend the randomized interventional approach to time‐to‐event outcomes, where both intermediate and terminal events are subject to right censoring. We envision a random draw for the intermediate event process from a reference distribution, either marginally over time‐varying confounders or conditionally given the observed history. We present the identification formula for interventional effects. We also discuss some variants of the identification assumptions. We estimate the treatment effects using nonparametric maximum likelihood estimation and propose a sensitivity analysis that incorporates a latent frailty. As an illustration, we study the effect of matched unrelated donor versus haploidentical donor on death mediated by relapse in a hematopoietic cell transplantation study with graft‐versus‐host disease (GVHD) as the time‐varying confounder. We find that matched unrelated donor transplantation is preferable in terms of survival rates under the use of post‐transplant PTCy GVHD prophylaxis for lymphoma patients.
Biometrics Causal Inference · 发表于 2026-05-21,收录于 2026-05-22
Yao Song, Kelly Speth, Amy Kilbourne, Andrew Quanbeck, Daniel Almirall, Lu Wang
摘要
A clustered adaptive intervention (cAI) is a prespecified sequence of decision rules that guides practitioners on how best—and based on which measures—to tailor cluster-level intervention to improve outcomes at the level of individuals within the clusters. A clustered sequential multiple assignment randomized trial (cSMART) is a type of trial that is used to inform the empirical development of a cAI. A common analytic goal in a cSMART focuses on assessing causal effect moderation by candidate tailoring variables. We introduce a clustered Q-learning framework with the M-out-of-N cluster bootstrap using data from a cSMART to evaluate whether a set of candidate tailoring variables may be useful in defining an optimal cAI. This approach could construct confidence intervals (CIs) with near-nominal coverage to assess parameters indexing the causal effect moderation function. Specifically, it allows reliable inferences concerning the utility of candidate tailoring variables in constructing a cAI that maximizes a mean end-of-study outcome even when “non-regularity,” a well-known challenge, exists. Simulations demonstrate the numerical performance of the proposed method across varying non-regularity conditions and investigate the impact of varying numbers of clusters and intra-cluster correlation coefficients on CI coverage. Methods are applied on the ADEPT dataset to inform the construction of a clinic-level cAI for improving evidence-based practice in treating mood disorders.
JASA Other · 发表于 2026-05-21,收录于 2026-05-29
T. Tony Cai, Abhinav Chakraborty, Yichen Wang
摘要
Data privacy is a central concern in many applications involving ranking from incomplete and noisy pairwise comparisons, such as recommendation systems, educational assessments, and opinion surveys on sensitive topics. In this work, we propose differentially private algorithms for ranking based on pairwise comparisons. Specifically, we develop and analyze ranking methods under two privacy notions: edge differential privacy, which protects the confidentiality of individual comparison outcomes, and individual differential privacy, which safeguards potentially many comparisons contributed by a single individual. Our algorithms—including a perturbed maximum likelihood estimator and a noisy count-based method—are shown to achieve minimax optimal rates of convergence under the respective privacy constraints. We further demonstrate the practical effectiveness of our methods through experiments on both simulated and real-world data. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
Biometrics Survival Analysis Nonparametric & Semiparametric Causal Inference · 发表于 2026-05-21,收录于 2026-05-22
Jessica Gronsbell, Zachary R McCaw, Isabelle-Emmanuella Nogues, Xiangshan Kong, Tianxi Cai, Lu Tian, L J Wei
摘要
As standards of care advance, patients are living longer and once-fatal diseases are becoming manageable. Clinical trials increasingly focus on reducing disease burden, which can be quantified by the timing and occurrence of multiple non-fatal clinical events. Most existing methods for the analysis of multiple event-time data require stringent modeling assumptions that can be difficult to verify empirically, leading to treatment efficacy estimates that forego interpretability when the underlying assumptions are not met. Moreover, many methods do not appropriately account for informative terminal events, such as premature treatment discontinuation or death, which prevent the occurrence of subsequent events. To address these limitations, we derive and validate estimation and inference procedures for the area under the mean cumulative function (AUMCF), an extension of the restricted mean survival time to the multiple event-time setting. The AUMCF is clinically interpretable, properly accounts for terminal competing risks, and can be estimated nonparametrically. To enable covariate adjustment, we also develop an augmentation estimator that provides efficiency at least equaling, and often exceeding, the unadjusted estimator. The utility and interpretability of the AUMCF are illustrated with extensive simulation studies and through an analysis of multiple heart-failure-related endpoints using data from the Beta-Blocker Evaluation of Survival Trial. Our open-source R package MCC makes conducting AUMCF analyses straightforward and accessible.
JASA Other · 发表于 2026-05-21,收录于 2026-05-29
Alessia Caponera, Domenico Marinucci, Anna Vidotto
摘要
This paper investigates the asymptotic behavior of structural break tests in the harmonic domain for time dependent spherical random fields. In particular, we prove a functional central limit theorem result for the fluctuations over time of the sample spherical harmonic coefficients, under the null of isotropy and stationarity; furthermore, we prove consistency of the corresponding CUSUM test, under a broad range of alternatives, including deterministic trend, abrupt change, and a nontrivial power alternative. Our results are then applied to NCEP data on global temperature: our estimates suggest that Climate Change does not simply affect global average temperatures, but also the nature of spatial fluctuations at different scales. *(abstract via OpenAlex)*
Biometrics Latent Variables & Mixtures Longitudinal Data Bayesian Methods · 发表于 2026-05-21,收录于 2026-05-22
Yuyang He, Xinyuan Song, Kai Kang
摘要
Mixed membership models are frequently utilized to capture complex individual heterogeneity in multivariate and longitudinal data. A key aspect of mixed membership modeling involves determining the number of extreme profiles (classes), a task traditionally managed through inefficient criterion-based methods. This task is particularly challenging when the predictors within the models are latent and derived from multiple observed variables using exploratory factor analysis. In this paper, we consider an innovative mixed membership latent variable model, which consists of an exploratory factor model to identify latent factors and a mixed membership model with latent predictors. We develop an efficient approach that integrates parameter estimation and model selection for the number of factors, extreme profiles, and the structure of the factor loading matrix. Our approach comprises a modified stochastic search item selection algorithm to automatically determine the number of latent factors and their associated manifest variables and a Bayesian penalized method to select the number of extreme profiles. We validate our methodology through extensive simulation studies, demonstrating its accuracy and efficiency in both parameter estimation and model selection. Applying this method to data from the Parkinson’s Progression Markers Initiative, we identify clinically important latent traits and distinct disease profiles. The results underscore our model’s enhanced ability to depict the intricate individual heterogeneity present in Parkinson’s disease patients.
Biometrics Longitudinal Data Diagnostics & Prediction Survival Analysis · 发表于 2026-05-21,收录于 2026-05-22
Mingyan Yu, Zhenke Wu, Michelle M Hood, Carrie Karvonen-Gutierrez, Siobán D Harlow, Michael R Elliott
摘要
Longitudinal biomarker data and health outcomes are routinely collected in many studies to assess how biomarker trajectories predict health outcomes. Existing methods primarily focus on mean biomarker profiles, treating variability as a nuisance. However, excess variability may indicate system dysregulations that may be associated with poor outcomes. In this paper, we address the long-standing problem of using variability information of multiple longitudinal biomarkers in time-to-event analyses by formulating and studying a Bayesian joint model. We first model multiple longitudinal biomarkers, some of which are subject to limit-of-detection censoring. We then model the survival times by incorporating random effects and variances from the longitudinal component as predictors through threshold regression that admits nonproportional hazards. We demonstrate the operating characteristics of the proposed joint model through simulations and apply it to data from the Study of Women’s Health Across the Nation to investigate the impact of the mean and variability of follicle-stimulating hormone and anti-Müllerian hormone on age at the final menstrual period.